Skip to content

Clinical trials

Borderline Personality Disorder trials in the United States with no applicable phase

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Borderline Personality Disorder Phase: Not applicable Country / region: United States Clear all

38 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20021
20041
20051
20062
20101
20111
20121
20131
20144
20161
20172
20192
20203
20212
20224
20234
20243
20252

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed24
Recruiting6
Unknown status5
Active, not recruiting1
Suspended1
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Icahn School of Medicine at Mount Sinai5
Bronx VA Medical Center2
Duke University2
Massachusetts General Hospital2
Mclean Hospital2
Rutgers, The State University of New Jersey2
Shannon E. Sauer-Zavala2
Stanford University2
University of California, Los Angeles2
University of Minnesota2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Borderline Personality Disorder38
Anxiety Disorders3
Stress Disorders, Post-Traumatic3
Bipolar Disorder2
Feeding and Eating Disorders2
Major Depressive Disorder2
Obsessive-Compulsive Disorder2
Substance-Related Disorders2
Attention Deficit Disorder with Hyperactivity1
Brain Injuries, Traumatic1

Trials

Showing 1 to 25 of 38. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.